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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
Primary
To identify whether follow up by healthcare professionals or lay organisations at any time affects the psychological well being of women
following miscarriage.
Secondary
To compare the effects of different types of interventions on the psychological well being of women following miscarriage.
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B A C K G R O U N D
Description of the condition
Although definitions of miscarriage vary internationally, it is de-
fined by the World Health Organization as the premature expul-
sion of an embryo or fetus from the uterus up to 23 weeks of
pregnancy and weighing up to 500 grams (WHO 2001). Early
pregnancy loss is defined as a confirmed empty sac or sac with
fetus but with no fetal heart activity at less than 12 weeks’ gesta-
tion (Farquharson 2005; RCOG 2006). It is difficult to quantify
precisely how many women will have a miscarriage but Rai 2006
suggest that between 25% and 50% of women will experience this
event.
This review will focus on spontaneous miscarriage and will not
include elective termination of pregnancy, ectopic pregnancy, still-
birth and neonatal death.
There are various categorisations of miscarriage, in that a miscar-
riage may be complete with all the products of conception passed
or incomplete in which some of the products are retained within
the uterus. There is an additional category of ‘silent’ miscarriage
or early fetal demise in which the fetus may have been dead for
some weeks but has not yet been expelled from the uterus (Trinder
2006). The characteristic symptoms of miscarriage are vaginal
blood loss which may be accompanied by pain.
Physical management of women with miscarriage in the UK op-
timally involves rapid referral to an early pregnancy unit with ul-
trasound confirmation that the pregnancy is not viable. Manage-
ment will depend on the category of miscarriage and the woman’s
clinical condition; women may be offered the option of expectant
management where there is no active medical intervention with
the miscarriage proceeding of its own accord. Other options are
surgical management, in which the retained products of concep-
tion are evacuated usually under general anaesthetic; and medical
intervention, in which medications are given to induce uterine
contractions and evacuation of retained products usually without
the need for surgical intervention (RCOG 2006). Systematic re-
views by Nanda 2010 and Neilson 2010 suggest that all of these
treatments are acceptable andwomen should be supported tomake
the choice of treatment which is most suitable for them.
Unlike physical management of women following miscarriage, the
evidence on psychological management is less well developed and
will be the focus of this review. There has been increased awareness
of the psychological consequences of miscarriage for women and
their partners. International studies using diagnostic tools iden-
tified that some women suffer from anxiety and depression after
miscarriage (Neugebauer 1997; Nikcevic 1999; Stirtzinger 1999).
These and other feelings that women describe have been concep-
tualised by many as being part of a pattern of grief in response to
the loss of a baby (Frost 2007;Malacrida 1998;Mander 1997). Ac-
counts from women about their hospital experiences in one study
were critical of how health professionals cared for them with little
awareness of their feelings of distress and no effective interventions
to support them (Stratton 2008).
Description of the intervention
Strategies to provide some kind of psychological follow up after
miscarriage have been proposed. However, these are characterised
by their diversity both in terms of the type of follow up and who
provides it. They range from telephone counselling provided by
women who have already had a miscarriage to more formal coun-
selling programmes. The mode of intervention could be passive,
such as written or electronic information, or active, via telephone,
clinic appointment or one-to-one or group support.
How the intervention might work
Follow up might detect those women who are at risk of develop-
ing or who actually have psychological complications following
miscarriage such as anxiety, distress and depression. The United
Kingdom RCOG guidelines (RCOG 2006) on the management
of women after early pregnancy loss state that support and coun-
selling for women after miscarriage can have significant positive
effects on psychological well being. However, a Cochrane review
of support after perinatal death, concluded that there is insuffi-
cient information that such interventions are beneficial (Flenady
2008). Similarly, Stratton 2008 in a review of hospital-based in-
terventions, found little evidence to suggest that follow up after
miscarriage has positive outcomes. It is possible that psychologi-
cal follow up could reduce any adverse effects on women such as
on their employment, relationships with their partners and other
close family members.
Why it is important to do this review
Currently once any complications are detected via follow up,
women can be referred to specific agencies which will provide in-
terventions to manage these complications and reduce any adverse
psychological outcomes following miscarriage. There is a need to
systematically review the evidence on follow up after miscarriage
as it is not known which interventions are effective.
O B J E C T I V E S
Primary
To identify whether follow up by healthcare professionals or lay
organisations at any time affects the psychological well being of
women following miscarriage.
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Secondary
To compare the effects of different types of interventions on the
psychological well being of women following miscarriage.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All published and unpublished randomised controlled trials in-
cluding cluster trials that compare different methods of follow up
after miscarriage. We will not include quasi-randomised trials (e.g.
trials that allocate treatment by sequential record number, sequen-
tial admitting number, by day of the week).
Types of participants
Females of child-bearing age experiencing miscarriage defined as
premature expulsion of an embryo or fetus from the uterus up
to 23 weeks of pregnancy and weighing up to 500 grams (WHO
2001).
Types of interventions
We will consider trials if they compare interventions following
miscarriage:
1. Psychological intervention versus no intervention.
2. Psychological intervention versus usual care.
3. Psychological intervention versus another psychological
intervention.
Types of outcome measures
We will consider trials if any of the following outcomes are re-
ported.
Primary outcomes
1. Psychological well being as defined by the trial authors.
2. Patient satisfaction as defined by the trial authors.
Secondary outcomes
1. Adverse reaction to follow up.
2. Referral to primary healthcare services.
3. Admission to hospital.
4. Costs associated with follow up.
Search methods for identification of studies
Electronic searches
We will contact the Trials Search Co-ordinator to search the
Cochrane Pregnancy and Childbirth Group’s Trials Register.
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. quarterly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. handsearches of 30 journals and the proceedings of major
conferences;
4. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL and MEDLINE,
the list of handsearched journals and conference proceedings, and
the list of journals reviewed via the current awareness service can
be found in the ‘Specialized Register’ section within the edito-
rial information about the Cochrane Pregnancy and Childbirth
Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
Searching other resources
We will search reference lists of all retrieved papers for additional
studies and contact professional and lay organisations in order to
obtain any ongoing or unpublished data.
We will not apply any language restrictions.
Data collection and analysis
We will assess all potential trials for eligibility according to the
criteria specified in the protocol by screening the titles and ab-
stracts. We will retrieve full reports of potentially relevant trials for
assessment of eligibility based on the inclusion criteria. All review
authors will extract the data and check for accuracy, and we will
resolve discrepancies by discussion. We will include studies pub-
lished in duplicate only once. If data are missing, or if only the
abstract is available, we will attempt to contact the trial authors to
obtain the missing information. We will resolve any disagreement
through discussion or, if required, we will consult the Pregnancy
and Childbirth Review Group.
Selection of studies
All review authors will independently assess for inclusion all the
potential studies we identify as a result of the search strategy.
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Data extraction and management
Wewill design a form to extract data. For eligible studies, all review
authors will extract the data using the agreed form. We will enter
data into ReviewManager software (RevMan 2008) and check for
accuracy.
When information regarding any of the above is unclear, we will
attempt to contact authors of the original reports to provide further
details.
Assessment of risk of bias in included studies
All review authors will independently assess risk of bias for each
study using the criteria outlined in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2009).
(1) Sequence generation (checking for possible selection
bias)
We will describe for each included study the method used to gen-
erate the allocation sequence in sufficient detail to allow an assess-
ment of whether it should produce comparable groups.
We will assess the method as:
• adequate (any truly random process, e.g. random number
table; computer random number generator);
• inadequate (any non-random process, e.g. odd or even date
of birth; hospital or clinic record number); or
• unclear.
(2) Allocation concealment (checking for possible selection
bias)
We will describe for each included study the method used to
conceal the allocation sequence in sufficient detail and determine
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We will assess the methods as:
• adequate (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• inadequate (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear.
(3) Blinding (checking for possible performance bias)
We will describe for each included study the methods used, if
any, to blind study participants and personnel from knowledge of
which intervention a participant received. We will judge studies
at low risk of bias if they were blinded, or if we judge that the
lack of blinding could not have affected the results. We will assess
blinding separately for different outcomes or classes of outcomes.
We will assess the methods as:
• adequate, inadequate or unclear for partial blinding of
participants;
• adequate, inadequate or unclear for partial blinding of
personnel;
• adequate, inadequate or unclear for outcome assessors.
(4) Incomplete outcome data (checking for possible attrition
bias through withdrawals, dropouts, protocol deviations)
We will describe for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We will state whether attrition and
exclusions were reported, the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information is reported, or can be supplied by
the trial authors, we will re-include missing data in the analyses
which we undertake. We will assess a study as adequate if less than
20% of primary outcome data are missing. We will assess methods
as:
• adequate;
• inadequate:
• unclear.
(5) Selective reporting bias
We will describe for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We will assess the methods as:
• adequate (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
• inadequate (where not all the study’s pre-specified outcomes
have been reported; one or more reported primary outcomes were
not pre-specified; outcomes of interest are reported incompletely
and so cannot be used; study fails to include results of a key
outcome that would have been expected to have been reported);
• unclear.
(6) Other sources of bias
We will describe for each included study any important concerns
we have about other possible sources of bias.
Were the groups similar at baseline regarding the most important
prognostic indicators?
Groups have to be similar at baseline regarding demographic fac-
tors and length of gestation. Alternatively if there were imbalances
at baseline these have been accounted for in the analysis of the
study.
Was the study stopped early?
If the study was stopped before the full sample has been recruited
there should be a clear rationale.
We will assess whether each study was free of other problems that
could put it at risk of bias:
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• yes;
• no;
• unclear.
(7) Overall risk of bias
We will make explicit judgements about whether studies are at
high risk of bias, according to the criteria given in the Handbook
(Higgins 2009). With reference to (1) to (6) above, we will assess
the likely magnitude and direction of the bias and whether we
consider it is likely to impact on the findings. We will explore the
impact of the level of bias through undertaking sensitivity analyses
- see Sensitivity analysis.
Measures of treatment effect
Dichotomous data
For dichotomous data, we will present results as summary risk
ratio with 95% confidence intervals.
Continuous data
For continuous data, we will use the mean difference if outcomes
are measured in the same way between trials. We will use the
standardised mean difference to combine trials that measure the
same outcome, but use different methods.
Unit of analysis issues
Cluster-randomised trials
We will include cluster-randomised trials in the analyses along
with individually randomised trials. We will adjust their sample
sizes using the methods described in the Handbook using an esti-
mate of the intracluster correlation co-efficient (ICC) derived from
the trial (if possible), or from another source. If ICCs from other
sources are used, we will report this and conduct sensitivity analy-
ses to investigate the effect of variation in the ICC. If we identify
both cluster-randomised trials and individually-randomised trials,
we plan to synthesise the relevant information. We will consider
it reasonable to combine the results from both if there is little het-
erogeneity between the study designs and the interaction between
the effect of intervention and the choice of randomisation unit is
considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a separate meta-analysis.
Dealing with missing data
For included studies, wewill note levels of attrition.Wewill explore
the impact of including studies with high levels of missing data
in the overall assessment of treatment effect by using Sensitivity
analysis.
For all outcomes we will carry out analyses, as far as possible, on an
intention-to-treat basis, i.e. we will attempt to include all partic-
ipants randomised to each group in the analyses. The denomina-
tor for each outcome in each trial will be the number randomised
minus any participants whose outcomes are known to be missing.
Assessment of heterogeneity
We will assess statistical heterogeneity in each meta-analysis using
the T², I² and Chi² statistics. We will regard heterogeneity as
substantial if T² is greater than zero and either I² is greater than
30% or there is a low P-value (less than 0.10) in the Chi² test for
heterogeneity.
Assessment of reporting biases
If there are 10 or more studies in the meta-analysis we will in-
vestigate reporting biases (such as publication bias) using funnel
plots. We will assess funnel plot asymmetry visually, and use for-
mal tests for funnel plot asymmetry. For continuous outcomes we
will use the test proposed by Egger 1997, and for dichotomous
outcomes we will use the test proposed by Harbord 2006. If we
detect asymmetry in any of these tests or by a visual assessment,
we will perform exploratory analyses to investigate it.
Data synthesis
We will carry out statistical analysis using the Review Manager
software (RevMan 2008). We will use fixed-effect inverse variance
meta-analysis for combining data where trials are examining the
same intervention, and the trials’ populations and methods are
judged sufficiently similar. Where we suspect clinical or method-
ological heterogeneity between studies sufficient to suggest that
treatment effects may differ between trials, we will use random-
effects meta-analysis.
If we identify substantial heterogeneity in a fixed-effect meta-anal-
ysis we will note this and repeat the analysis using a random-effects
method.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses.
1. Recurrent miscarriage versus sporadic miscarriage.
2. Early versus late miscarriage
3. Pre-existing psychological condition versus no
psychological condition.
We will use the following outcome in subgroup analysis.
• Psychological well being.
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For fixed-effect meta-analyses, we will conduct planned subgroup
analyses classifying whole trials by interaction tests as described by
Deeks 2001. For random-effects meta-analyses we will assess dif-
ferences between subgroups by inspection of the subgroups’ con-
fidence intervals; non-overlapping confidence intervals indicate a
statistically significant difference in treatment effect between the
subgroups.
Sensitivity analysis
We will carry out sensitivity analyses to explore the effect of trial
quality separating using the risk of bias table to distinguish high-
quality from low-quality trials, for example in allocation conceal-
ment and blinding of outcome assessors.
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